Novus Scientific Announces the Sales Launch for TIGRâ„¢ Matrix Surgical Mesh - World's 1st Long-Term Resorbable Synthetic Mesh
CANTON, Mass., June 17 /PRNewswire/ -- Novus Scientific, Inc. today announced the US sales launch of TIGR™ Matrix Surgical Mesh at the Abdominal Wall Reconstruction meeting, Washington DC. In February 2010, the US Food and Drug Administration (FDA) cleared, TIGR™ Matrix Surgical Mesh for use in reinforcement of soft tissues where weakness exists.
"The TIGR™ prosthetic adds a tool to the surgeon's armamentarium that is currently missing – a long acting, synthetic, absorbable product that may not only be beneficial in hernia patients, but also for prophylaxis, potentially preventing the hernia from ever forming in the first place," said David Earle MD FACS, Assistant Professor of Surgery, Tufts University School of Medicine, Springfield, MA.
TIGR™ Matrix Surgical Mesh is knitted from two different resorbable fibers that degrade at different rates following implantation. This unique patented dual-fibre design provides an initial high strength / high stability configuration, with gradually increasing compliance over time as the device is resorbed. The macroporous structure is designed to allow tissue integration for reliable tissue repair.
"TIGR™ Matrix Surgical
Meshbegins a new era in patient treatment.While there is a wide range of potential applications for such a
unique product, at today's Abdominal Wall Reconstruction meeting
there has been particular interest in use of TIGR™
Matrix for onlay or sublay reinforcement in conjunction
with the component s '/>"/>